Inovio Pharmaceuticals

Bronze Sponsor

Inovio Pharmaceuticals is developing DNA immunotherapies and vaccines to prevent and treat cancers and infectious diseases. Our DNA-based immunotherapies, in combination with our proprietary CELLECTRA® delivery devices, are designed to break the immune system’s tolerance of cancerous cells. In the context of infectious diseases, our immunotherapies are intended to facilitate cross-strain protection against known as well as new unmatched strains of pathogens.